83
Views
11
CrossRef citations to date
0
Altmetric
Original Research

Oxaliplatin-incorporated micelles eliminate both cancer stem-like and bulk cell populations in colorectal cancer

, , , , , , , & show all
Pages 3207-3218 | Published online: 06 Dec 2011

References

  • DeanMFojoTBatesSTumour stem cells and drug resistanceNat Rev Cancer20055427528415803154
  • ReyaTMorrisonSJClarkeMFWeissmanILStem cells, cancer, and cancer stem cellsNature2001414685910511111689955
  • TodaroMAleaMPDi StefanoABColon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4Cell Stem Cell20071438940218371377
  • DalerbaPChoRWClarkeMFCancer stem cells: models and conceptsAnnu Rev Med20075826728417002552
  • DalerbaPDyllaSJParkIKPhenotypic characterization of human colorectal cancer stem cellsProc Natl Acad Sci U S A200710424101581016317548814
  • YeungTMGandhiSCWildingJLMuschelRBodmerWFCancer stem cells from colorectal cancer-derived cell linesProc Natl Acad Sci U S A201010783722372720133591
  • DingXWWuJHJiangCPABCG2: a potential marker of stem cells and novel target in stem cell and cancer therapyLife Sci20108617–1863163720159023
  • PangRLawWLChuACA subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancerCell Stem Cell20106660361520569697
  • Charafe-JauffretEGinestierCIovinoFAldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancerClin Cancer Res2010161455520028757
  • GuptaPBChafferCLWeinbergRACancer stem cells: mirage or reality?Nat Med20091591010101219734877
  • FanXOuyangNTengHYaoHIsolation and characterization of spheroid cells from the HT29 colon cancer cell lineInt J Colorectal Dis201126101279128521670985
  • LimMCSongYJSeoSSYooCWKangSParkSYResidual cancer stem cells after interval cytoreductive surgery following neoadjuvant chemotherapy could result in poor treatment outcomes for ovarian cancerOnkologie201033632433020523098
  • RichJNBaoSChemotherapy and cancer stem cellsCell Stem Cell20071435335518371369
  • ManiSAGuoWLiaoMJThe epithelial-mesenchymal transition generates cells with properties of stem cellsCell2008133470471518485877
  • YangADFanFCampERChronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell linesClin Cancer Res200612144147415316857785
  • GuptaPBOnderTTJiangGIdentification of selective inhibitors of cancer stem cells by high-throughput screeningCell2009138464565919682730
  • SchultzPGDubrovskaAElliottJCombination therapy targeting both tumor-initiating and differentiated cell populations in prostate carcinomaClin Cancer Res201016235692570221138868
  • DuYZWengQYuanHHuFQSynthesis and antitumor activity of stearate-g-dextran micelles for intracellular doxorubicin deliveryACS Nano20104116894690220939508
  • DuYZCaiLLLiJReceptor-mediated gene delivery by folic acid-modified stearic acid-grafted chitosan micellesInt J Nanomedicine201161559156821845046
  • JeongYIKim doHChungCWDoxorubicin-incorporated polymeric micelles composed of dextran-b-poly(DL-lactide-co-glycolide) copolymerInt J Nanomedicine201161415142721796244
  • WuYWangWChenYThe investigation of polymer-siRNA nanoparticle for gene therapy of gastric cancer in vitroInt J Nanomedicine2010512913620309399
  • DiaoYYLiHYFuYHDoxorubicin-loaded PEG-PCL copolymer micelles enhance cytotoxicity and intracellular accumulation of doxorubicin in adriamycin-resistant tumor cellsInt J Nanomedicine201161955196221976972
  • TalelliMImanMRijckenCJvan NostrumCFHenninkWETargeted core-crosslinked polymeric micelles with controlled release of covalently entrapped doxorubicinJ Control Release20101481121122
  • MatsumuraYMaedaHA new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancsCancer Res19864612638763922946403
  • HuFQRenGFYuanHDuYZZengSShell cross-linked stearic acid grafted chitosan oligosaccharide self-aggregated micelles for controlled release of paclitaxelColloids Surf B Biointerfaces20065029710316759840
  • Hyung ParkJKwonSLeeMSelf-assembled nanoparticles based on glycol chitosan bearing hydrophobic moieties as carriers for doxorubicin: in vivo biodistribution and anti-tumor activityBiomaterials200627111912616023198
  • HuFQWuXLDuYZYouJYuanHCellular uptake and cytotoxicity of shell crosslinked stearic acid-grafted chitosan oligosaccharide micelles encapsulating doxorubicinEur J Pharm Biopharm200869111712517997293
  • HuFQLiuLNDuYZYuanHSynthesis and antitumor activity of doxorubicin conjugated stearic acid-g-chitosan oligosaccharide polymeric micellesBiomaterials200930366955696319782395
  • DuYZWangLYuanHHuFQLinoleic acid-grafted chitosan oligosaccharide micelles for intracellular drug delivery and reverse drug resistance of tumor cellsInt J Biol Macromol201148121522221093477
  • ZhangXGMiaoJDaiYQDuYZYuanHHuFQReversal activity of nanostructured lipid carriers loading cytotoxic drug in multi-drug resistant cancer cellsInt J Pharm20083611–223924418586075
  • XuYYDuYZYuanHLiuLNNiuYPHuFQImproved cytotoxicity and multidrug resistance reversal of chitosan based polymeric micelles encapsulating oxaliplatinJ Drug Target201119534435320854014
  • AlbertsSRHorvathWLSternfeldWCOxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group Phase II studyJ Clin Oncol200523369243924916230673
  • CassidyJTaberneroJTwelvesCXELOX (capecitabine plus oxaliplatin): active first-line therapy for patients with metastatic colorectal cancerJ Clin Oncol200422112084209115169795
  • GoldbergRMSargentDJMortonRFA randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancerJ Clin Oncol2004221233014665611
  • ZhouBBZhangHDamelinMGelesKGGrindleyJCDirksPBTumour-initiating cells: challenges and opportunities for anticancer drug discoveryNat Rev Drug Discov200981080682319794444
  • TrumppAWiestlerODMechanisms of Disease: cancer stem cells – targeting the evil twinNat Clin Pract Oncol20085633734718431377
  • JohannessenTCBjerkvigRTysnesBBDNA repair and cancer stem- like cells – potential partners in glioma drug resistance?Cancer Treat Rev200834655856718501520
  • CammareriPLombardoYFrancipaneMGBonventreSTodaroMStassiGIsolation and culture of colon cancer stem cellsMethods Cell Biol20088631132418442654
  • Ricci-VitianiLLombardiDGPilozziEIdentification and expansion of human colon-cancer-initiating cellsNature2007445712311111517122771
  • VermeulenLTodaroMde Sousa MelloFSingle-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacityProc Natl Acad Sci U S A200810536134271343218765800
  • WangYKZhuYLQiuFMActivation of Akt and MAPK pathways enhances the tumorigenicity of CD133+ primary colon cancer cellsCarcinogenesis20103181376138020530554
  • LiYZhangTKorkayaHSulforaphane, a dietary component of broccoli/broccoli sprouts, inhibits breast cancer stem cellsClin Cancer Res20101692580259020388854